Browsing by Subject "Angiotensin Receptor Antagonists"
Now showing items 1-2 of 2
Alport syndrome from bench to bedside: The potential of current treatment beyond RAAS blockade and the horizon of future therapies (2014)The hereditary type IV collagen disease Alport syndrome (AS) always leads to end-stage renal failure. Yesterday, for the past 90 years, this course was described as 'inevitable'. Today, RAAS blockade has changed the ...
(2016)Alport syndrome (AS) is a hereditary progressive glomerulonephritis with a high life-time risk for end-stage renal disease (ESRD). Most patients will reach ESRD before the age of 30 years, while a subset of them with milder ...